![EU General Court demands a vigorous effects-based analysis for rebates cases and annuls the European Commission's Intel decision and the €1.06 billion fine | White & Case LLP EU General Court demands a vigorous effects-based analysis for rebates cases and annuls the European Commission's Intel decision and the €1.06 billion fine | White & Case LLP](https://www.whitecase.com/sites/default/files/styles/original_image/public/images/hero/2022/08/client_alerts_option_13_4000x1500.jpg?itok=rwssgGPL)
EU General Court demands a vigorous effects-based analysis for rebates cases and annuls the European Commission's Intel decision and the €1.06 billion fine | White & Case LLP
![EU news: How Jacques Chirac tried to get Britain to SCRAP Thatcher's EU rebate | UK | News | Express.co.uk EU news: How Jacques Chirac tried to get Britain to SCRAP Thatcher's EU rebate | UK | News | Express.co.uk](https://cdn.images.express.co.uk/img/dynamic/1/590x/brexit-brexit-news-brexit-latest-european-union-eu-eu-news-margaret-thatcher-tony-blair-rebate-uk-rebate-macron-news-1116023.jpg?r=1569498879833)
EU news: How Jacques Chirac tried to get Britain to SCRAP Thatcher's EU rebate | UK | News | Express.co.uk
![The UK 'rebate' on the EU budget: An explanation of the abatement and other correction mechanisms | Epthinktank | European Parliament The UK 'rebate' on the EU budget: An explanation of the abatement and other correction mechanisms | Epthinktank | European Parliament](https://i0.wp.com/epthinktank.eu/wp-content/uploads/2016/02/eprs-briefing-577973-uk-rebate-on-the-eu-budget.jpg?fit=900%2C600&ssl=1)
The UK 'rebate' on the EU budget: An explanation of the abatement and other correction mechanisms | Epthinktank | European Parliament
![Patients' access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe - The Lancet Regional Health – Europe Patients' access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/ef27ab91-7896-474a-ba95-2ff0cc12cc42/gr1_lrg.jpg)
Patients' access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe - The Lancet Regional Health – Europe
![David Cameron told fighting £1.7bn demand could hurt UK's EU rebate | European Commission | The Guardian David Cameron told fighting £1.7bn demand could hurt UK's EU rebate | European Commission | The Guardian](https://i.guim.co.uk/img/static/sys-images/Guardian/Pix/pictures/2014/10/27/1414417431748/David-Cameron-012.jpg?width=465&quality=85&dpr=1&s=none)